The store will not work correctly when cookies are disabled.
1-[(1E)-1-ethyl-2-(4-methoxyphenyl)but-1-enyl]-4-methoxybenzene
ID: ALA113650
Chembl Id: CHEMBL113650
Cas Number: 130-79-0
PubChem CID: 3032539
Max Phase: Preclinical
Molecular Formula: C20H24O2
Molecular Weight: 296.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC/C(=C(/CC)c1ccc(OC)cc1)c1ccc(OC)cc1
Standard InChI: InChI=1S/C20H24O2/c1-5-19(15-7-11-17(21-3)12-8-15)20(6-2)16-9-13-18(22-4)14-10-16/h7-14H,5-6H2,1-4H3/b20-19+
Standard InChI Key: VQOAQMIKPYNCMV-FMQUCBEESA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 296.41 | Molecular Weight (Monoisotopic): 296.1776 | AlogP: 5.43 | #Rotatable Bonds: 6 |
Polar Surface Area: 18.46 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.49 | CX LogD: 5.49 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.66 | Np Likeness Score: -0.08 |
References
1. Mestres J, Veeneman GH.. (2003) Identification of "latent hits" in compound screening collections., 46 (16): [PMID:12877579] [10.1021/jm034078c] |
2. Hodnik Ž, Tomašič T, Smodiš D, D'Amore C, Mašič LP, Fiorucci S, Kikelj D.. (2015) Diethylstilbestrol-scaffold-based pregnane X receptor modulators., 103 [PMID:26408814] [10.1016/j.ejmech.2015.09.005] |
3. Laiolo J, Tomašič T, Vera DMA, González ML, Lanza PA, Gancedo SN, Hodnik Ž, Peterlin Mašič L, Kikelj D, Carpinella MC.. (2018) Analogues of the Lignan Pinoresinol as Novel Lead Compounds for P-glycoprotein (P-gp) Inhibitors., 9 (12): [PMID:30613324] [10.1021/acsmedchemlett.8b00324] |